Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for quarter ended 30th June, 2025.
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has submitted a routine compliance certificate to the stock exchanges for the quarter ended 30th June 2025. The certificate was issued by the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited. It confirms that all physical share certificates received for dematerialisation during the quarter were duly processed, confirmed to the depositories, and the corresponding entries were updated in the register of members within the required timelines. The certificates were mutilated and cancelled after verification, with the depository's name substituted as the registered owner.
This is a standard quarterly compliance filing with no material business or financial impact. It does not affect the company's operations, financials, or shareholder value in any direct way.